carvedilol has been researched along with monocrotaline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, A; Dalla Libera, L; Danieli Betto, D; Germinario, E; Gobbo, V; Ravara, B; Vescovo, G | 1 |
| Bijnens, B; Friedberg, MK; Gomez, O; Honjo, O; Ishii, R; Okumura, K; Sun, M | 1 |
2 other study(ies) available for carvedilol and monocrotaline
| Article | Year |
|---|---|
Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Male; Monocrotaline; Muscle Proteins; Muscle, Skeletal; Myofibrils; Oxidation-Reduction; Propanolamines; Rats; Rats, Sprague-Dawley | 2005 |
Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Carvedilol; Disease Models, Animal; Drug Therapy, Combination; Heart Rate; Hypertension, Pulmonary; Ivabradine; Male; Monocrotaline; Rats, Sprague-Dawley; Recovery of Function; Time Factors; Ventricular Function, Left; Ventricular Function, Right | 2018 |